IgG4相关疾病的胃肠道及肠外表现
本文综述IgG4相关疾病(IgG4-RD)的胃肠道及肠外表现,该病为慢性复发性多器官纤维炎性综合征,以血清IgG4升高及组织IgG4+细胞浸润为特征。典型表现为几乎任何器官的肿块样同步或异时性病变,最常见于胰腺、胆管、腹膜后、肾脏、肺、涎腺及泪腺、眼眶和淋巴结。炎症可被糖皮质激素及利妥昔单抗等B细胞清除药物减轻,患者有复发但对初始治疗有反应,纤维化可致永久性器官损伤,死亡罕见,预后极佳。
要点
- IgG4-RD为慢性复发性多器官纤维炎性综合征,以血清IgG4升高及组织IgG4+细胞浸润为特征。
- 典型表现为几乎任何器官的肿块样同步或异时性病变,最常见于胰腺、胆管、腹膜后、肾脏、肺、涎腺及泪腺、眼眶和淋巴结。
- 炎症可被糖皮质激素及利妥昔单抗等B细胞清除药物减轻,患者有复发但对初始治疗有反应,死亡罕见,预后极佳。
核心结论
- IgG4-RD是一种以胰腺胆道受累为主的多器官疾病,尽管病程复发缓解,但患者预后极佳。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- 组织学分析显示IgG4-RD患者组织有密集的淋巴浆细胞浸润富含IgG4+浆细胞、席纹状纤维化和闭塞性静脉炎,但这些特征因器官而异。
- 典型表现和影像学发现包括几乎任何器官的肿块样同步或异时性病变,最常见于胰腺、胆管、腹膜后、肾脏、肺、涎腺及泪腺、眼眶和淋巴结。
- 所有器官的炎症均可被糖皮质激素和利妥昔单抗等B细胞清除药物减轻。
- IgG4-RD患者有复发,对初始治疗有反应;强烈纤维化伴随炎症反应,导致永久性器官损伤和功能不全;死于IgG4-RD罕见。
关键数值与推荐
- 原文未报告具体诊断标准或数值阈值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IgG4-related disease (IgG4-RD) is a chronic relapsing multi-organ fibro-inflammatory syndrome of presumed autoimmune etiology. It is characterized by increased serum levels of IgG4 and tissue infiltration by IgG4+ cells. Increased titers of autoantibodies against a spectrum of self-antigens and response to steroids have led to its characterization as an autoimmune disease. However, the pathognomonic antigens probably differ among manifestations, and different antigens or autoantibodies produce similar immune reactions in different organs. Little is known about the pathogenic effects, if any, of serum IgG4 or IgG4+ plasma cells in tissues. Despite several animal models of the disease, none truly recapitulates human IgG4-RD. Histologic analyses of tissues from patients with IgG4-RD reveal a dense lymphoplasmacytic infiltrate rich in IgG4+ plasma cells, storiform fibrosis, and obliterative phlebitis, although these features vary among organs. Typical presentation and imaging findings include mass-forming synchronous or metachronous lesions in almost any organ, but most commonly in the pancreas, bile duct, retroperitoneum, kidneys, lungs, salivary and lacrimal glands, orbit, and lymph nodes. In all organs, inflammation can be reduced by corticosteroids and drugs that deplete B cells, such as rituximab. Patients with IgG4-RD have relapses that respond to primary therapy. Intense fibrosis accompanies the inflammatory response, leading to permanent organ damage and insufficiency. Death from IgG4-RD is rare. IgG4-RD is a multi-organ disease with predominant pancreatico-biliary involvement. Despite its relapsing-remitting course, patients have an excellent prognosis.
引用
- Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and Extra-Intestinal Manifestations of IgG4-Related Disease. Gastroenterology. 2018. PMID: 30012334. doi:10.1053/j.gastro.2018.06.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。